GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » KBL Merger Corp IV (NAS:KBLM) » Definitions » Investments And Advances

Switch to:

KBL Merger IV (KBL Merger IV) Investments And Advances : $0.00 Mil (As of Jun. 2020)

View and export this data going back to 2017. Start your Free Trial

What is KBL Merger IV Investments And Advances?

KBL Merger IV's Investments And Advances for the quarter that ended in Jun. 2020 was $0.00 Mil.

KBL Merger IV Investments And Advances Historical Data

The historical data trend for KBL Merger IV's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KBL Merger IV Investments And Advances Chart

KBL Merger IV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Investments And Advances

-

-

-

-

KBL Merger IV Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20
Investments And Advances	Get a 7-Day Free Trial										-	-	-	-	-

KBL Merger IV Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

KBL Merger IV (KBL Merger IV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » KBL Merger Corp IV (NAS:KBLM) » Definitions » Investments And Advances

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Park Place, Suite 45E, New York, NY, USA, 10007

Website

https://www.kblmerger.com

KBL Merger Corp IV is a blank check company.

KBL Merger IV (KBL Merger IV) Headlines

From GuruFocus

Promising Biotechs Choosing SPAC for Speed, Capital, Visibility

By Marketwired Marketwired • 10-14-2020

Development of Next-Generation Drugs to Inhibit Ravages of Chronic Inflammation

By Marketwired Marketwired • 10-05-2020

KBL Merger Corp. IV Announces Change of Special Meeting of Shareholders Date to November 5, 2020

By Marketwired Marketwired • 10-23-2020

KBL Merger Corp. IV SPAC Successfully Completes Bridge Financing

By PRNewswire PRNewswire • 06-29-2020

UPDATE: 180 Life Sciences Corp. Expands Intellectual Property Portfolio

By Marketwired Marketwired • 10-06-2020

KBL Merger Corp. IV Announces Approval of Business Combination with 180 Life Sciences at the Special Meeting of Shareholders Held on November 5, 2020

By Marketwired Marketwired • 11-06-2020

KBL Merger Corp. IV SPAC Signs Definitive Business Combination Agreement to Acquire CannBioRx Life Sciences Corp.

By PRNewswire PRNewswire • 07-26-2019

KBL Merger Corp. IV Announces Completion of Acquisition of 180 Life Sciences Corp. and Trading Under the ticker ATNF Starting November 9, 2020

By Marketwired Marketwired • 11-09-2020

Innovative Companies with Blockbuster Potential Catch SPAC Attention

By Marketwired Marketwired • 10-23-2020

UPDATE -- The Quest for Blockbuster Drugs Continues

By Marketwired Marketwired • 10-21-2020

Home About Jobs Site Map Term of Use Privacy Policy Mobile App Referral Program Partner Program FAQ Contact Us 中文 All-In-One Screener
Stock List Guru List Insider List Insider Trade Economic Indicators Industry Data DCF Calculator Discussion Board Plans Excel Add-In Google Sheets Add-on
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.